Use of a High-Purity Factor X Concentrate in Turkish Subjects with Hereditary Factor X Deficiency: Post Hoc Cohort Subanalysis of a Phase 3 Study

Use of a High-Purity Factor X Concentrate in Turkish Subjects with Hereditary Factor X Deficiency: Post Hoc Cohort Subanalysis of a Phase 3 Study

Hereditary factor X (FX) deficiency is a rare bleeding disorder more prevalent in countries with high rates of consanguineous marriage. In a prospective, open-label, multicenter phase 3 study, 25 IU/kg plasmaderived factor X (pdFX) was administered as on-demand treatment or short-term prophylaxis fo...

Full description

Bibliographic Details
Main Authors: Ahmet F. Öner, Tiraje Celkan, Çetin Timur, Miranda Norton, Kaan Kavaklı
Format: Article
Language:English
Published: Galenos Publishing House 2018-05-01
Series:Turkish Journal of Hematology
Subjects:
clinical trial
clotting factor concentrate
efficacy
factor x deficiency
orphan drug
safety
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-46872

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-46872

Similar Items